Rabbit

Identification

Name
Rabbit
Accession Number
DB10415
Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Allergenics
Allergen Extract
Description

Rabbit allergenic extract is used in allergenic testing.

Synonyms
Not Available
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
RabbitInjection, solution0.05 g/1mLSubcutaneousAlk Abello, Inc.1965-01-01Not applicableUs
RabbitInjection, solution0.05 g/1mLPercutaneousALK-Abello, Inc.1965-01-01Not applicableUs
RabbitInjection, solution0.10 g/1mLSubcutaneousAlk Abello, Inc.1965-01-01Not applicableUs
RabbitInjection, solution20000 [PNU]/1mLSubcutaneousAlk Abello, Inc.1965-01-01Not applicableUs
RabbitInjection, solution10000 [PNU]/1mLSubcutaneousAlk Abello, Inc.1965-01-01Not applicableUs
RabbitInjection, solution1000 [PNU]/1mLIntradermalALK-Abello, Inc.1965-01-01Not applicableUs
Rabbit MeatInjection, solution0.05 g/1mLIntradermal; SubcutaneousAntigen Laboratories, Inc.1974-03-23Not applicableUs
Categories
UNII
O5V0F26RUW
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347910584
Wikipedia
Rabbit

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1RecruitingTreatmentMyeloid Diseases1
1TerminatedTreatmentMyasthenia Gravis1
1TerminatedTreatmentMyopathies1
1TerminatedTreatmentVasculitis1
1, 2RecruitingTreatmentSevere Combined Immunodeficiency1
2Active Not RecruitingTreatmentHemoglobinuria, Paroxysmal Nocturnal (PNH) / Juvenile Myelomonocytic Leukemia (JMML) / Leukemia Acute Myeloid Leukemia (AML) / Leukemia, Acute Lymphocytic (ALL) / Leukemia, Myeloid, Chronic(CML) / Lymphoma, Hodgkins / Lymphoma, Non-Hodgkin (NHL) / Myelodysplastic Syndromes (MDS)1
2Active Not RecruitingTreatmentLeukemias1
2CompletedPreventionAcute Renal Allograft Rejection / Cadaveric Donor Renal Transplantation / Induction Therapy1
2CompletedTreatmentChronic Chronic myelogenous leukemia / Chronic Lymphocytic Leukaemia (CLL) / Leukemia Acute Myeloid Leukemia (AML) / Leukemias / Lymphoma, Hodgkins / Multiple Myeloma (MM) / Myelodysplastic Syndrome / Non-Hodgkin's Lymphoma (NHL)1
2CompletedTreatmentGenetic Disorders / Malignancies / Metabolic Diseases1
2CompletedTreatmentImmunosuppresion / Neutropenias / Pancytopenia / Thrombocytopenias1
2CompletedTreatmentLeukemia, Mast-Cell / Mantle Cell Lymphoma (MCL)1
2CompletedTreatmentLymphohistiocytosis, Hemophagocytic1
2CompletedTreatmentRejection, Transplant / Transplantation, Renal1
2RecruitingTreatmentAcute Lymphoblastic Leukaemias (ALL) / Chronic Myeloid Leukemia (CML) / Granulocytic Sarcoma / Juvenile Myelomonocytic Leukemia (JMML) / Leukemia Acute Myeloid Leukemia (AML) / Myelodysplastic Syndromes (MDS) / Non-Hodgkin's Lymphoma (NHL)1
2RecruitingTreatmentAcute Myelogenous Leukaemia (AML) / Congenital Hypoplastic Anemia / Myelodysplastic Syndromes (MDS)1
2RecruitingTreatmentHematopoietic/Lymphoid Cancer1
2RecruitingTreatmentLeukemias / Malignant Lymphomas / Myeloproliferative Disorders / Plasma Cell Myeloma1
2RecruitingTreatmentTransplant, Kidney1
2TerminatedTreatmentAcute Lymphoblastic Leukaemias (ALL) / Acute Myelocytic Leukemia / Chronic Myeloid Leukemia (CML) / Granulocytic Sarcoma / Hodgkin's or Non-Hodgkin's Lymphoma / Juvenile Myelomonocytic Leukemia / Myelodysplastic Syndrome1
2TerminatedTreatmentPrimary Renal Allograft Candidate / Transplantation, Kidney1
2TerminatedTreatmentPrimary Simultaneous Kidney and Pancreas Allograft Candidates / Simultaneous Kidney and Pancreas Transplantation1
2, 3RecruitingTreatmentScleroderma / Sclerosis, Progressive Systemic1
3Unknown StatusPreventionMalignancies, Hematologic1
4Unknown StatusTreatmentImmunosuppression / Liver Diseases / Transplantation, Liver1
Not AvailableCompletedNot AvailableAcute Lymphocytic Leukemia (ALL) / Acute Myelogenous Leukaemia (AML) / Graft Versus Host Disease (GVHD)1
Not AvailableCompletedTreatmentChronic Allograft Nephropathy (CAN) / Transplantation, Kidney1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Injection, solutionIntradermal1000 [PNU]/1mL
Injection, solutionPercutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.10 g/1mL
Injection, solutionSubcutaneous10000 [PNU]/1mL
Injection, solutionSubcutaneous20000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on December 01, 2015 13:03 / Updated on November 02, 2018 07:04